Security Analysis

Security Analysis

Share this post

Security Analysis
Security Analysis
LabCorp (LH)

LabCorp (LH)

Value Stock Geek's avatar
Value Stock Geek
Dec 17, 2023
∙ Paid
8

Share this post

Security Analysis
Security Analysis
LabCorp (LH)
Share

Key Statistics

EV/EBIT = 19x

ROE = 6.98%

Debt/Equity = 80%

FCF Yield = 4.3%

Dividend Yield = 1.3%

Market Capitalization = $18.64 billion

The Company

LabCorp (LH), officially known as Laboratory Corporation of America Holdings, is a healthcare company focusing on testing and research. They play a pivotal role in disseminating crucial information to medical professionals, hospitals, and researchers.

LabCorp operates through two main segments: Dx (Diagnostic) and DD (Drug Development). In 2022, Dx contributed 61% of the company's revenues, primarily in the US, while DD contributed 39%, with revenues evenly split between the US and the rest of the world.

LabCorp has benefited from increases in testing services. Patient blood work has increased in frequency over the decades, with various tests emerging for a variety of different uses.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Value Stock Geek
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share